Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Anteris Technologies stock price, quote, forecast and news

AVR.AX
AU0000088841

Price

15.42 AUD
Today +/-
+0.25 AUD
Today %
+2.76 %
P

Anteris Technologies stock price

AUD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Anteris Technologies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Anteris Technologies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Anteris Technologies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Anteris Technologies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Anteris Technologies Stock Price History

DateAnteris Technologies Price
8/16/202415.42 AUD
8/15/202415.00 AUD
8/14/202414.56 AUD
8/13/202414.70 AUD
8/12/202414.23 AUD
8/9/202414.24 AUD
8/8/202413.85 AUD
8/7/202414.00 AUD
8/6/202414.10 AUD
8/5/202414.38 AUD
8/2/202414.90 AUD
8/1/202415.15 AUD
7/31/202415.30 AUD
7/30/202415.14 AUD
7/29/202415.14 AUD
7/26/202415.52 AUD
7/25/202415.61 AUD
7/24/202416.00 AUD
7/19/202417.21 AUD

Anteris Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Anteris Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Anteris Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Anteris Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Anteris Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Anteris Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Anteris Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Anteris Technologies’s growth potential.

Anteris Technologies Revenue, EBIT and net profit per share

DateAnteris Technologies RevenueAnteris Technologies EBITAnteris Technologies Net Income
2026e5.68 M AUD-93.14 M AUD-72.06 M AUD
2025e5.68 M AUD-82.65 M AUD-71.82 M AUD
2024e5.68 M AUD-76.92 M AUD-76.05 M AUD
20237.03 M AUD-67.72 M AUD-67.33 M AUD
20226.73 M AUD-45.25 M AUD-44.34 M AUD
20219.27 M AUD-21.53 M AUD-22.91 M AUD
20209.57 M AUD-14.34 M AUD-15.27 M AUD
201917.15 M AUD-24.85 M AUD-5.82 M AUD
201825.71 M AUD-24.55 M AUD-24.22 M AUD
201711.71 M AUD-8.5 M AUD-8.63 M AUD
201622.49 M AUD-12.17 M AUD-12.31 M AUD
201514.34 M AUD-25.06 M AUD-24.01 M AUD

Anteris Technologies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M AUD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M AUD)EBIT (M AUD)EBIT MARGIN (%)NET INCOME (M AUD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e2026e
14221125179967555
-57.14-50.00127.27-32.00-47.06--33.3316.67-28.57--
35.7145.4563.6448.0047.0666.6777.7866.6771.43---
51071286745000
-25-12-8-24-24-14-21-45-67-76-82-93
-178.57-54.55-72.73-96.00-141.18-155.56-233.33-750.00-957.14-1,520.00-1,640.00-1,860.00
-24-12-8-24-5-15-22-44-67-76-71-72
--50.00-33.33200.00-79.17200.0046.67100.0052.2713.43-6.581.41
1.912.512.553.065.95.917.4213.3615.61000
------------
Details

Keystats

ⓘ

Revenue and Growth

The Anteris Technologies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Anteris Technologies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M AUD)RECEIVABLES (M AUD)OTHER REC. (M AUD)INVENTORIES (M AUD)OTHER CURRENT LIAB. (M AUD)CURRENT ASSETS (M AUD)TANGIBLE ASSETS (M AUD)LONG-T. INVEST. (M AUD)LONG-T. REC. (k AUD)INTANGIBLE ASSETS (M AUD)GOODWILL (M AUD)OTHER NON-CURRENT ASSETS (k AUD)NON-CURRENT ASSETS (M AUD)TOTAL ASSETS (M AUD)LIABILITIESCOMMON STOCK (M AUD)ADDITIONAL PAID-IN CAPITAL (M AUD)RETAINED EARNINGS (M AUD)OTHER EQUITY (k AUD)UNREAL. GAINS/LOSSES (M AUD)EQUITY (M AUD)LIABILITIES (M AUD)PROVISIONS (M AUD)OTHER SHORT-TERM LIAB. (M AUD)SHORT-TERM DEBTS (M AUD)LONG-TERM DEBT PORTION (M AUD)SHORT-TERM REC. (M AUD)LONG-T. LIAB. (M AUD)DEFERRED TAXES (M AUD)OTHER LIAB. (M AUD)LONG-T. LIABILITIES (M AUD)DEBT (M AUD)TOTAL CAPITAL (M AUD)
201520162017201820192020202120222023
8.8111.268.2512.0416.114.3521.313.8130.83
2.333.264.083.190.610.850.280.650.6
1.881.030.6412.050.742.30.180.67
3.594.455.556.691.810.690.760.520.65
000001.461.22.93.14
16.622018.5322.9220.588.0925.8418.0735.89
2.72.363.683.472.992.432.54.527.83
000000000
0000729.68711.1400610.05
5.874.634.323.881.71.421.150.91.38
1.591.591.591.5900000
00248.94000000
10.168.589.848.945.424.563.645.419.81
26.7828.5828.3731.862612.6529.4823.4845.7
87.89106.03106.03137.74137.76138.74172.64211.83282.99
000000000
-67.6-83.46-91.74-115.95-121.4-136.26-157.47-197.11-253.38
464.1363.31-205.61-674.73-818.56-74.57-822.11-1,506.85-1,006.96
000000000
20.7522.9314.0821.1215.542.4114.3513.2228.6
2.61.965.452.471.130.753.072.554.59
1.070.750.881.020.530.470.4800.62
00.40.45.284.23.664.084.237.64
004.77000000
000.2501.452.955.310.760.98
3.673.1211.748.777.37.8412.947.5413.83
00002.171.771.632.031.53
000000000
0.471.491.71.6110.640.560.691.68
0.471.491.71.613.172.42.192.723.21
4.144.6113.4410.3810.4710.2415.1310.2617.04
24.8927.5427.5331.52612.6529.4823.4845.64
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Anteris Technologies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Anteris Technologies's financial health and stability.

Assets

Anteris Technologies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Anteris Technologies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Anteris Technologies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Anteris Technologies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M AUD)DEPRECIATION (k AUD)DEFERRED TAXES (M AUD)CHANGES IN WORKING CAPITAL (M AUD)NON-CASH ITEM (M AUD)PAID INTEREST (M AUD)PAID TAXES (M AUD)NET CASH FLOW FROM OPERATING ACTIVITIES (M AUD)CAPITAL EXPENDITURES (M AUD)CASH FLOW FROM INVESTING ACTIVITIES (M AUD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M AUD)INTEREST INCOME AND EXPENSES (M AUD)NET DEBT CHANGE (M AUD)NET CHANGE IN EQUITY (M AUD)CASH FLOW FROM FINANCING ACTIVITIES (M AUD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (AUD)TOTAL DIVIDENDS PAID (M AUD)NET CHANGE IN CASH FLOW (M AUD)FREE CASH FLOW (M AUD)SHARE-BASED COMPENSATION (M AUD)
20152016null201720182019202020212022
0000000-22-44
000000001,000
000000000
344000211
000000002
000000000
000000000
-21-12-12-6-22-22-14-18-38
000-10000-2
0-2-2-1-1207-1-1
0-2-20020801
000000000
0005-5001-2
71818035013634
71717427013631
--1.00-1.00--3.00---1.00-1.00
000000000
-40-142-9-17-25-21-3-48
-22.33-12.740-7.77-22.82-22.93-14.66-19.58-41.4
000000000

Anteris Technologies stock margins

The Anteris Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Anteris Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Anteris Technologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Anteris Technologies's sales revenue. A higher gross margin percentage indicates that the Anteris Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Anteris Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Anteris Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Anteris Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Anteris Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Anteris Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Anteris Technologies Margin History

Anteris Technologies Gross marginAnteris Technologies Profit marginAnteris Technologies EBIT marginAnteris Technologies Profit margin
2026e77.32 %-1,640.37 %-1,269.02 %
2025e77.32 %-1,455.57 %-1,264.89 %
2024e77.32 %-1,354.77 %-1,339.34 %
202377.32 %-963.56 %-958.11 %
202270.54 %-672.74 %-659.22 %
202182.3 %-232.38 %-247.21 %
202071.54 %-149.85 %-159.66 %
201948.85 %-144.91 %-33.93 %
201848.81 %-95.48 %-94.19 %
201760.41 %-72.55 %-73.7 %
201648.45 %-54.1 %-54.75 %
201537.03 %-174.78 %-167.48 %

Anteris Technologies Stock Sales Revenue, EBIT, Earnings per Share

The Anteris Technologies earnings per share therefore indicates how much revenue Anteris Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Anteris Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Anteris Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Anteris Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Anteris Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Anteris Technologies Revenue, EBIT and net profit per share

DateAnteris Technologies Sales per ShareAnteris Technologies EBIT per shareAnteris Technologies Earnings per Share
2026e0.27 AUD0 AUD-3.41 AUD
2025e0.27 AUD0 AUD-3.4 AUD
2024e0.27 AUD0 AUD-3.6 AUD
20230.45 AUD-4.34 AUD-4.31 AUD
20220.5 AUD-3.39 AUD-3.32 AUD
20211.25 AUD-2.9 AUD-3.09 AUD
20201.62 AUD-2.42 AUD-2.58 AUD
20192.91 AUD-4.21 AUD-0.99 AUD
20188.42 AUD-8.04 AUD-7.93 AUD
20174.6 AUD-3.33 AUD-3.39 AUD
20168.95 AUD-4.84 AUD-4.9 AUD
20157.51 AUD-13.13 AUD-12.58 AUD

Anteris Technologies business model

Anteris Technologies Ltd is a groundbreaking British company specialized in researching, developing, and manufacturing innovative medical instruments and implants. It was founded in 2009 by a group of experienced scientists and entrepreneurs and has since had an impressive track record of success. The company's business model is based on utilizing state-of-the-art technology and collaborating with leading medical experts worldwide. Anteris Technologies aims to develop high-quality instruments and implants that enable fast and effective recovery and improve people's lives. The company offers various divisions covering different medical areas, with a focus on orthopedics, neurosurgery, and cardiology. Its orthopedic division focuses on manufacturing implants for treating bone fractures, injuries, and degenerative diseases, including bone replacement products, joint replacement products, and spinal surgery products. The company strives to develop implants that closely resemble natural body parts and facilitate rapid and effective recovery. Its neurosurgery division concentrates on researching and developing products for treating neurological diseases and injuries to the nervous system, such as spinal cord injuries, brain tumors, and epilepsy, in close collaboration with leading neurology experts. The cardiology division focuses on researching and developing products for treating heart diseases and heart attacks, including stents to maintain normal blood flow in the heart and catheters used for minimally invasive surgical procedures. One of the company's notable products is the Vascular Flow Technologies (VFT) Stent, designed specifically for treating coronary heart disease, which features a unique surface coating that reduces the risk of blood clots and enables faster healing. Anteris Technologies is also working on developing new advanced instruments to simplify surgical procedures and reduce recovery time. Overall, Anteris Technologies Ltd has become one of the leading companies in the medical industry. Its experts are dedicated to pushing the boundaries of modern medical treatment and helping patients heal faster and more effectively. With its innovative products and excellent expertise, the company will continue to play a crucial role in the medical industry and improving people's health. Anteris Technologies is one of the most popular companies on Eulerpool.com.

Anteris Technologies SWOT Analysis

Strengths

Anteris Technologies Ltd possesses several strengths that contribute to its success in the market. The company has a strong portfolio of innovative medical technologies and products, which gives it a competitive edge. Additionally, their extensive research and development capabilities enable them to continuously create new solutions and stay ahead of the curve.

Weaknesses

Despite its strengths, Anteris Technologies Ltd also faces a few weaknesses that it needs to address. One weakness is the company's heavy reliance on a limited number of key clients for revenue generation, which poses a potential risk if there are any disruptions in these partnerships. Another weakness is the lack of diversified product offerings, making them vulnerable to market fluctuations in certain segments.

Opportunities

Anteris Technologies Ltd has identified several opportunities that could fuel its growth. The increasing demand for advanced medical technologies and solutions presents a significant growth opportunity for the company. By expanding into new geographical markets and forging strategic partnerships, Anteris can tap into untapped markets and expand its customer base. Additionally, the growing focus on healthcare advancements and investment in medical research offers opportunities for collaboration and product development.

Threats

Like any company, Anteris Technologies Ltd also faces potential threats that may impact its business. One major threat is competitive pressure from larger and more established players in the medical technology industry. Additionally, regulatory changes and compliance requirements pose a risk, as non-compliance could result in penalties and delays in product launches. Market volatility and economic uncertainties can also impact customer spending, affecting the demand for Anteris' products and services.

Anteris Technologies Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Anteris Technologies historical P/E ratio, EBIT, and P/S ratio.

Anteris Technologies shares outstanding

The number of shares was Anteris Technologies in 2023 — This indicates how many shares 15.606 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Anteris Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Anteris Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Anteris Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Anteris Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Anteris Technologies Stock splits

In Anteris Technologies's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Anteris Technologies.

Anteris Technologies list of shareholders

%
Name
Stocks
Change
Date
4.88 % Sio Capital Management, LLC1,032,50504/10/2024
2.30 % Evolution Capital Advisors Pty. Ltd.486,3877,3964/10/2024
13.45 % L1 Capital Pty Ltd.2,843,39804/10/2024
10.12 % Perceptive Advisors LLC2,140,00004/10/2024
1.80 % Neumann (Ricky Steven)380,27069,4964/10/2024
1.62 % Chew (Patrick)343,35528,8004/10/2024
1.28 % Mutual Trust Pty. Ltd.271,411-64,2784/10/2024
1.27 % Rhenman & Partners Asset Management AB268,757238,7436/30/2023
1.26 % LTL Capital Pty. Ltd.266,761266,7614/10/2024
1.00 % Mishtalem Pty. Ltd.211,50077,5004/10/2024
1
2

Anteris Technologies Executives and Management Board

Mr. Wayne Paterson55
Anteris Technologies Chief Executive Officer, Managing Director, Executive Director (since 2014)
Compensation 3.56 M AUD
Mr. David St Denis
Anteris Technologies Chief Operating Officer
Compensation 1.68 M AUD
Mr. Matthew Mcdonnell
Anteris Technologies Chief Financial Officer
Compensation 826,007 AUD
Mr. John Seaberg
Anteris Technologies Non-Executive Independent Chairman of the Board
Compensation 723,057 AUD
Mr. Stephen Denaro
Anteris Technologies Company Secretary, Non-Executive Independent Director (since 2018)
Compensation 420,521 AUD
1
2

Anteris Technologies Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
HSBC Holdings Stock
HSBC Holdings
SupplierCustomer0,690,390,220,800,880,88
LeMaitre Vascular Stock
LeMaitre Vascular
SupplierCustomer0,070,280,45-0,56-0,830,30
1

Most common questions regarding Anteris Technologies

What values and corporate philosophy does Anteris Technologies represent?

Anteris Technologies Ltd represents values of exceptional innovation, integrity, and commitment to advancing healthcare solutions. With a strong corporate philosophy focused on revolutionizing regenerative medicine, Anteris Technologies is dedicated to improving patient outcomes through its cutting-edge technologies and therapeutic products. The company's unwavering dedication to research and development, combined with a patient-centric approach, ensures the delivery of high-quality and effective medical solutions. Anteris Technologies Ltd strives to be at the forefront of the industry, continuously pushing boundaries and offering groundbreaking advancements in regenerative medicine.

In which countries and regions is Anteris Technologies primarily present?

Anteris Technologies Ltd is primarily present in Australia.

What significant milestones has the company Anteris Technologies achieved?

Anteris Technologies Ltd has achieved several significant milestones. Notably, the company successfully completed the first-in-human implantation of its DurAVR™ aortic valve, demonstrating its commitment to revolutionizing cardiac surgery. Furthermore, Anteris Technologies received regulatory approval for DurAVR™ in Europe, marking a major step forward in expanding its market reach. The company also forged strategic collaborations with renowned medical institutions, enhancing its research and development capabilities. Anteris Technologies is continuously exploring opportunities for advancements in cardiovascular technologies and aims to provide innovative solutions to improve patient outcomes.

What is the history and background of the company Anteris Technologies?

Anteris Technologies Ltd is a leading biotechnology company headquartered in Australia. Founded in 2003, the company focuses on developing and commercializing cutting-edge medical devices and regenerative therapeutics. Anteris Technologies is dedicated to advancing healthcare through innovative solutions that address unmet medical needs across various therapeutic areas. With a team of highly skilled scientists, researchers, and engineers, the company has successfully developed groundbreaking products that have the potential to revolutionize patient care. Anteris Technologies Ltd remains committed to continuous innovation and playing a significant role in shaping the future of the biotechnology industry.

Who are the main competitors of Anteris Technologies in the market?

The main competitors of Anteris Technologies Ltd in the market include companies like Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, and Abbott Laboratories.

In which industries is Anteris Technologies primarily active?

Anteris Technologies Ltd is primarily active in the medical and healthcare industries.

What is the business model of Anteris Technologies?

The business model of Anteris Technologies Ltd focuses on the development and commercialization of innovative medical technologies. As a leading provider in the healthcare industry, Anteris Technologies specializes in the design and production of advanced biomedical products aimed at enhancing patients' quality of life. With a strong emphasis on research and development, the company continuously strives to introduce groundbreaking solutions for various medical conditions. Anteris Technologies is committed to bringing revolutionary therapies and medical devices to market, ensuring better treatment options and improved outcomes for patients worldwide.

What is the P/E ratio of Anteris Technologies 2024?

The Anteris Technologies P/E ratio is -3.16.

What is the P/S ratio of Anteris Technologies 2024?

The Anteris Technologies P/S ratio is 42.38.

What is the AlleAktien quality score of Anteris Technologies?

The AlleAktien quality score for Anteris Technologies is 2/10.

What is the revenue of Anteris Technologies 2024?

The expected Anteris Technologies revenue is 5.68 M AUD.

How high is the profit of Anteris Technologies 2024?

The expected Anteris Technologies profit is -76.05 M AUD.

What is the business model of Anteris Technologies

Anteris Technologies Ltd is a company specialized in medical technology. The company's business model is based on the development and commercialization of innovative products focused on the treatment of heart and vascular diseases. The company is divided into three main areas: 1. Heart valve and stent technology: Anteris Technologies develops innovative heart valve and stent technologies that enable improved treatment for patients with heart and vascular diseases. These products offer higher performance, better adaptability to the patient's anatomical conditions, and increased compatibility. 2. Closure and implant systems: Anteris Technologies has also developed closure and implant systems that enable effective treatment for patients with vascular diseases. These products are capable of opening blocked or damaged blood vessels and improving blood flow. 3. Research and development: Anteris Technologies also invests in research and development to drive the development of innovative technologies. Through collaboration with leading research institutions and clinical partners, the company can develop and bring new solutions in medical technology to the market. Anteris Technologies' products are designed for a wide range of applications and can be used to treat various medical issues. These include coronary artery disease, aortic valve disease, heart valve disease, and peripheral arterial occlusive disease. The company distributes its products through a network of distribution partners and medical professionals. Sales and marketing are conducted by an experienced team of professionals with extensive experience in the medical technology industry. Anteris Technologies also aims to work closely with medical professionals to develop innovative solutions and constantly improve its products. To achieve this, the company collaborates closely with a variety of partners, including doctors, hospitals, and research institutes. In recent years, the company has experienced strong growth and has been able to establish a strong presence in the global market. This was facilitated by the introduction of innovative products that enable effective and safe treatment of heart and vascular diseases. Overall, Anteris Technologies has developed a strong business model based on the development of innovative medical technology products and collaboration with leading medical professionals. The company continues to strive to advance the development of new innovative products and improve medical care worldwide.

What is the Anteris Technologies dividend?

Anteris Technologies pays a dividend of 0 AUD distributed over payouts per year.

How often does Anteris Technologies pay dividends?

The dividend cannot currently be calculated for Anteris Technologies or the company does not pay out a dividend.

What is the Anteris Technologies ISIN?

The ISIN of Anteris Technologies is AU0000088841.

What is the Anteris Technologies ticker?

The ticker of Anteris Technologies is AVR.AX.

How much dividend does Anteris Technologies pay?

Over the past 12 months, Anteris Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Anteris Technologies is expected to pay a dividend of 0 AUD.

What is the dividend yield of Anteris Technologies?

The current dividend yield of Anteris Technologies is .

When does Anteris Technologies pay dividends?

Anteris Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Anteris Technologies?

Anteris Technologies paid dividends every year for the past 0 years.

What is the dividend of Anteris Technologies?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Anteris Technologies located?

Anteris Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Anteris Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Anteris Technologies from 8/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 8/17/2024.

When did Anteris Technologies pay the last dividend?

The last dividend was paid out on 8/17/2024.

What was the dividend of Anteris Technologies in the year 2023?

In the year 2023, Anteris Technologies distributed 0 AUD as dividends.

In which currency does Anteris Technologies pay out the dividend?

The dividends of Anteris Technologies are distributed in AUD.

All fundamentals about Anteris Technologies

Our stock analysis for Anteris Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anteris Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.